SCHEMBL7212237

SCHEMBL7212237

CCC([S+]([O-])CCC[S+]([O-])CCCC(C)(C)C(=O)OC)C(C)(C)C(=O)OC

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.30
CYP4A11 Q02928 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6505133 0.83 CYP4F2 (0.36) CYP4F2CYP4A11
SCHEMBL6691583 0.77 CYP4F2 (0.40) CYP4F2CYP4A11
SCHEMBL6502656 0.77 CYP4F2 (0.33) CYP4F2CYP4A11
SCHEMBL6692896 0.76 CYP4F2 (0.42) CYP4F2CYP4A11
SCHEMBL27596099 0.72 ACLY (0.42) CYP4F2CYP4A11
SCHEMBL27578128 0.71 ACLY (0.45) CYP4F2CYP4A11
SCHEMBL6709910 0.70 DGAT1 (0.33) CYP4F2CYP4A11
SCHEMBL27596160 0.68 ACACB (0.39) CYP4F2CYP4A11
SCHEMBL6503462 0.65 ACLY (0.47)
SCHEMBL1245575 0.65 CYP4F2 (0.46) CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1366024-A2 SULFOXIDE AND BIS-SULFOXIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-12-03 EP disclosed
WO-2002030882-A2 SULFOXIDE AND BIS-SULFOXIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO disclosed